Association of microRNA-499 rs3746444 polymorphism with cancer risk: Evidence from 7188 cases and 8548 controls

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Wang, Fang ^a   Sun, Guoping ^a   Zou, Yanfeng ^a   Li, Yuanyuan ^a   Hao, Li ^a   Pan, Faming ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 499; UNCLASSIFIED DRUG; MIRN499 MICRORNA, HUMAN;

ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; META ANALYSIS; RISK ASSESSMENT; RISK FACTOR; VALIDATION STUDY; CASE CONTROL STUDY; CLASSIFICATION; GENETIC PREDISPOSITION; GENETICS; NEOPLASM;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 84874272955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045042     Document Type: Article

References (36)

1. Kanavos P (2006) The rising burden of cancer in the developing world. Ann Oncol 17:viii15-viii23.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61:69-90.
3. Foulkes WD (2008) Inherited susceptibility to common cancers. N Engl J Med 359:2143-2153.
4. Cai Y, Yu X, Hu S, Yu J (2009) A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics 7:147-154.
5. Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: Approaches and considerations. Nat Rev Genet 13:358-369.
6. Landi D, Moreno V, Guino E, Vodicka P, Pardini B, et al. (2011) Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: A review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. Mutat Res 717:109-115.
7. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-866.
8. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6:259-269.
9. Xiang Y, Fan S, Cao J, Huang S, Zhang LP (2012) Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep 39:7019-7023.
10. Alshatwi AA, Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, et al. (2012) Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One 7:e30049.
11. Zhou J, Lv R, Song X, Li D, Hu X, et al. (2012) Association Between Two Genetic Variants in miRNA and Primary Liver Cancer Risk in the Chinese Population. DNA Cell Biol 31:524-530.
12. Min KT, Kim JW, Jeon YJ, Jang MJ, Chong SY, et al. (2011) Association of the miR-146aC.G, 149C.T, 196a2C.T, and 499A.G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog doi: 10.1002/mc.21849.
13. Mittal RD, Gangwar R, George GP, Mittal T, Kapoor R (2011) Investigative role of pre-microRNAs in bladder cancer patients: A case-control study in North India. DNA Cell Biol 30:401-406.
14. Zhou B, Wang K, Wang Y, Xi M, Zhang Z, et al. (2011) Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol Carcinog 50:499-505.
15. Akkiz H, Bayram S, Bekar A, Akgöllü E, Üsküdar O (2011) Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac J Cancer Prev 12:3107-3112.
16. George GP, Gangwar R, Mandal RK, Sankhwar SN, Mittal RD (2011) Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol Biol Rep 38:1609-1615.
17. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, et al. (2010) Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15:524-531.
18. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, et al. (2010) Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116:4753-4760.
19. Srivastava K, Srivastava A, Mittal B (2010) Common genetic variants in premicroRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet 55:495-499.
20. Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, et al. (2010) Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat 31:E1052-1057.
21. Tian T, Shu Y, Chen J, Hu Z, Xu L, et al. (2009) A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 18:1183-1187.
22. Hu Z, Liang J, Wang Z, Tian T, Zhou X, et al. (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30:79-84.
23. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6:e1000097.
24. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129.
25. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
26. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
27. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558.
28. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629-634.
29. Xu W, Xu J, Liu S, Chen B, Wang X, et al. (2011) Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: A meta-analysis. PLoS One 6:e20471.
30. Chu H, Wang M, Shi D, Ma L, Zhang Z, et al. (2011) Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One 6:e18108.
31. Qiu LX, He J, Wang MY, Zhang RX, Shi TY, et al. (2011) The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine 56:695-698.
32. Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, et al. (2011) miR-196a2 C allele is a low-penetrant risk factor for cancer development. Cytokine 56:589-592.
33. Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, et al. (2012) A genetic variant in microRNA-196a2 is associated with increased cancer risk: A meta-analysis. Mol Biol Rep 39:269-275.
34. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, et al. (2007) Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 81:829-834.
35. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105:7269-7274.
36. Liu R, Liao J, Yang M, Sheng J, Yang H, et al. (2012) The cluster of miR-143 and miR-145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin homolog 1. PLoS One 7:e33987.